<unk>  is a HMG-COA Reductase Inhibitor drug that is FDA approved for the treatment of hyperlipidemia, prevention of cardiovascular disease. Adverse reactions include diarrhea, arthralgia, myalgia, urinary tract infectious disease, nasopharyngitis, pain, in extremity.
Atorvastatin
Clofibrate
Mevastatin
Simvastatin
Fenofibrate
Lovastatin
Ezetimibe
Fluvastatin